USCOM LIMITED — Board/Management Information 2010

Jan 3, 2010

Uscom Limited ABN 35091028090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

M A R K E T A N N O U N C E M E N T

Management change for USCOM in 2010

Monday 4th January 2010: Uscom (ASX code: UCM) today announced that Mr Paul Butler will resign as CEO and Director in response to the ongoing international travel requirements related to the Company’s geographical market expansion. The Company is now seeking to recruit a new CEO, plus a Global Sales Manager to enhance the commercial management team. Nick Schicht will continue in his role as General Manager, while the position of interim CEO will be occupied by Mr Rob Phillips, the Uscom Executive Chairman. Paul Butler joined Uscom in 2002 and was appointed to the position of Uscom CEO in January 2007. From 1[st] February 2010 Paul will continue with Uscom on a consultative basis working on business development projects.

Rob Phillips, the Executive Chairman of Uscom and Director of Clinical Science said “Paul has been integral in determining the culture, strategy and operations of Uscom and leaves the CEO role with the Company in a strong position. Uscom has a strong global marketing partnership, good cash reserves and is poised for revenue growth, with additional strategic partnership opportunities in discussion. Prior to his appointment as CEO, Paul supervised the design and development of the USCOM device and was part of the management team which took the Company public. The Board of Directors is grateful to Paul for his energy, dedication and loyalty and we look forward to his on going contribution to Uscom.

We believe an expanded globally focussed management team will best capitalise on the rapidly evolving international opportunities and will mark 2010 as the beginning of a new growth phase for the Company as our worldwide marketing strategy begins to gain traction.”

About Uscom

Uscom Limited is an Australian medical device company which was first listed on the Australian Stock Exchange in December 2003. Uscom has developed a Non Invasive Cardiac Output Monitor. The USCOM is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency Medicine, Intensive Care Units and Anesthesia, and is a tool of choice for management of adult and paediatric sepsis, and for the guidance of all fluid administration. USCOM has global regulatory approval and the technology is currently marketed in North America, South America, Europe, the Middle East, India and Australia by Spacelabs Healthcare, while in China and SE Asia USCOM is distributed by Pacific Medical Systems and in New Zealand it is distributed by MedXus.

Uscom Contacts

Paul Butler Chief Executive Officer paul.butler@uscom.com.au

Rob Phillips Executive Chairman rob@uscom.com.au